New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients.
about
Assessing patients' anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodologyLong-term treatment of cancer-associated thrombosis: the choice of the optimal anticoagulant.Factors Affecting the Quality of Anticoagulation With Vitamin K Antagonists in Venous Thromboembolism Patients.Effectiveness and Safety of Anticoagulants for the Treatment of Venous Thromboembolism in Patients With Cancer.Anticoagulantes orais diretos no tratamento do tromboembolismo venoso em pacientes com câncer.2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
P2860
New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New orally active anticoagulan ...... boembolism in cancer patients.
@en
type
label
New orally active anticoagulan ...... boembolism in cancer patients.
@en
prefLabel
New orally active anticoagulan ...... boembolism in cancer patients.
@en
P2093
P2860
P356
P1476
New orally active anticoagulan ...... boembolism in cancer patients.
@en
P2093
Grigoris T Gerotziafas
Isabelle Mahé
Ismail Elalamy
P2860
P304
P356
10.2147/TCRM.S49063
P577
2014-06-13T00:00:00Z